Luminai, an AI-native enterprise automation platform purpose-built for healthcare operations, today announced the close of a $38 million Series B funding round, bringing total capital raised to $60 million. The round was led by Peak XV Partners (formerly Sequoia India & Southeast Asia), with participation from new investor Define Ventures and continued backing from existing investors, including General Catalyst and Y Combinator.

Luminai is an enterprise AI automation platform built for healthcare operations. The company helps health systems turn unstructured and fragmented data into trusted intelligence that powers high-accuracy, end-to-end automation across administrative and operational workflows. Luminai's platform combines healthcare-trained AI models, a configurable workflow engine and human-in-the-loop validation, with flexible deployment options including on-premises, customer-managed cloud and managed infrastructure.